LivaNova PLC (LIVN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:LivaNova PLC (LIVN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010985
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery, neuromodulation and cardiac rhythm management. The company’s neuromodulation segment provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for autotransfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. LivaNova offers cardiac rhythm management products such as implantable cardiac pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and patient management tools. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, the UK.

LivaNova PLC (LIVN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
LivaNova PLC , Medical Equipment, Deals By Year, 2011 to YTD 2017 6
LivaNova PLC , Medical Equipment Deals By Type, 2011 to YTD 2017 7
LivaNova PLC , Medical Equipment, Deals By Region, 2011 to YTD 2017 8
LivaNova PLC , Medical Equipment, Deals By Market, 2011 to YTD 2017 9
LivaNova PLC , Medical Equipment, Deals Summary, 2011 to YTD 2017 10
LivaNova PLC , Medical Equipment, Deal Details 11
Venture Financing 11
HighLife Raises USD12.3 Million in Venture Financing 11
MD Start Secures USD11.5 Million in Venture Funding 12
IMTHERA MEDICAL Secures US$4 Million In Series C Venture Financing 13
Partnerships 14
Cyberonics Enters Into Licensing Agreement With Imricor Medical Systems For Novel MRI Compatibility Lead Technology 14
Merger 15
Sorin Merges with Cyberonics for USD2.7 Billion 15
Asset Transactions 17
MicroPort Scientific to Acquire Cardiac Rhythm Management Business Franchise from LivaNova 17
Acquisition 18
LivaNova to Acquire ImThera Medical for Upto USD225 Million 18
LivaNova Acquires Remaining 51% Stake in Caisson Interventional 19
Mittel Plans to Sell 6% Interest in LivaNova 20
NorthCoast Asset Management Divests Stake in Cyberonics 21
Cyberonics Acquires Minority Stake In cerbomed, Provider Of Neuro-Therapy Solutions, For US$2.6 Million 22
LivaNova PLC – Key Competitors 23
LivaNova PLC – Key Employees 24
LivaNova PLC – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Strategy And Business Planning 27
Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization 27
Financial Announcements 28
Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results 28
Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results 30
May 03, 2017: LivaNova Reports First Quarter 2017 Results 32
Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 34
Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 35
Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results 38
Sep 29, 2016: LivaNova Announces Half-Year Financial Report 40
Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results 47
May 04, 2016: LivaNova Reports First Quarter 2016 Results 49
Feb 24, 2016: LivaNova Reports 2015 Annual and Fourth Quarter Financial Results 51
Corporate Communications 54
Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 54
May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer 55
Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 56
Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester 57
Aug 01, 2016: LivaNova Names Chief Operating Officer 58
Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors 59
Mar 03, 2016: LivaNova Announces Appointment of Vice President Investor Relations and Corporate Communications 60
Jan 13, 2016: LivaNova Announces Management Change 61
Legal and Regulatory 62
Jun 21, 2017: VNS Therapy Receives FDA Approval for Expanded MRI Labeling 62
Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 63
Jan 05, 2016: LivaNova Provides Update on FDA Warning Letter 64
Product News 65
Sep 22, 2016: LivaNova Launches Next Generation ICD and CRT-D Devices in the United States 65
03/08/2016: LivaNova Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery 66
02/29/2016: LivaNova Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve 67
02/01/2016: LivaNova Announces FDA Approval of Stented Heart Valve CROWN PRT for Aortic Valve Disease 68
01/28/2016: LivaNova Receives Regulatory Approval in Japan for KORA 250 69
Product Approvals 70
Feb 29, 2016: LivaNova Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve 70
Feb 01, 2016: LivaNova Announces FDA Approval of Stented Heart Valve CROWN PRT for Aortic Valve Disease 71
Jan 28, 2016: LivaNova Receives Regulatory Approval in Japan for KORA 250 72
Other Significant Developments 73
Sep 14, 2017: LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business Franchise 73
Aug 07, 2017: LivaNova Implements 3T Heater-Cooler Device Modification 74
Appendix 75
Methodology 75
About GlobalData 75
Contact Us 75
Disclaimer 75

List of Tables
LivaNova PLC , Medical Equipment, Key Facts, 2016 2
LivaNova PLC , Medical Equipment, Deals Summary, 2011 to YTD 2017 2
LivaNova PLC , Medical Equipment, Deals By Year, 2011 to YTD 2017 6
LivaNova PLC , Medical Equipment Deals By Type, 2011 to YTD 2017 7
LivaNova PLC , Medical Equipment, Deals By Region, 2011 to YTD 2017 8
LivaNova PLC , Deals By Market, 2011 to YTD 2017 9
LivaNova PLC , Medical Equipment, Deals Summary, 2011 to YTD 2017 10
HighLife Raises USD12.3 Million in Venture Financing 11
MD Start Secures USD11.5 Million in Venture Funding 12
IMTHERA MEDICAL Secures US$4 Million In Series C Venture Financing 13
Cyberonics Enters Into Licensing Agreement With Imricor Medical Systems For Novel MRI Compatibility Lead Technology 14
Sorin Merges with Cyberonics for USD2.7 Billion 15
MicroPort Scientific to Acquire Cardiac Rhythm Management Business Franchise from LivaNova 17
LivaNova to Acquire ImThera Medical for Upto USD225 Million 18
LivaNova Acquires Remaining 51% Stake in Caisson Interventional 19
Mittel Plans to Sell 6% Interest in LivaNova 20
NorthCoast Asset Management Divests Stake in Cyberonics 21
Cyberonics Acquires Minority Stake In cerbomed, Provider Of Neuro-Therapy Solutions, For US$2.6 Million 22
LivaNova PLC , Key Competitors 23
LivaNova PLC , Key Employees 24
LivaNova PLC , Subsidiaries 25

★海外企業調査レポート[LivaNova PLC (LIVN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verona Pharma Plc (VRP)-製薬・医療分野:企業M&A・提携分析
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • TVS Motor Co Ltd:戦略・SWOT・企業財務分析
    TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Simplex Infrastructures Ltd:企業の戦略・SWOT・財務分析
    Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ya-Man Ltd:企業の戦略・SWOT・財務分析
    Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report Summary Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TransAlta Corporation:企業の戦略・SWOT・財務情報
    TransAlta Corporation - Strategy, SWOT and Corporate Finance Report Summary TransAlta Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Zoologischer Garten Berlin AG:企業の戦略・SWOT・財務情報
    Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report Summary Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Kukje Pharmaceutical Industry Co Ltd (002720):企業の財務・戦略的SWOT分析
    Summary Kukje Pharmaceutical Industry Co Ltd (Kukje) is a manufacturer, and distributor of pharmaceuticals, cosmetics and healthcare products. The company’s products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, other antibiotics, antifungal and antiviral agents. Kukj …
  • Breakthru Beverage Group, LLC:企業の戦略・SWOT・財務分析
    Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Irving Oil Ltd:企業の戦略的SWOT分析
    Irving Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Enercon GmbH:企業の戦略的SWOT分析
    Enercon GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Eidgenossische Technische Hochschule Zurich-製薬・医療分野:企業M&A・提携分析
    Summary Eidgenossische Technische Hochschule Zurich(ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, bi …
  • Verde Science Inc-石油・ガス分野:企業M&A・提携分析
    Summary Verde Science Inc (Verde Science), formerly Rango Energy Inc is a medical technology company that offers bioprocess solutions. The company offers research and development services with expertise in bioprocess technology, molecular virology and immunology, nanotechnology, pharmacology and med …
  • S-Oil Corporation Inc (010950)-石油・ガス分野:企業M&A・提携分析
    Summary S-Oil Corporation Inc (S-Oil) is a service driven company that operates in the petroleum and petrochemical industry. The company imports and exports crude oil; as well as manufactures and sells oil refining products, petrochemical products and lube products. S-Oil also produces a wide range …
  • Amara Raja Batteries Ltd (AMARAJABAT):企業の財務・戦略的SWOT分析
    Summary Amara Raja Batteries Ltd (Amara Raja) operates as a manufacturer of lead-acid storage batteries. The company operates through two sectors automotive battery and industrial battery sectors. Its automotive battery sector offers two-wheeler batteries, four-wheeler batteries and tubular batterie …
  • ON Semiconductor Corporation:企業の戦略・SWOT・財務情報
    ON Semiconductor Corporation - Strategy, SWOT and Corporate Finance Report Summary ON Semiconductor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ZoomMed Inc (ZMD)-医療機器分野:企業M&A・提携分析
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • George Weston Limited (WN):企業の財務・戦略的SWOT分析
    George Weston Limited (WN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • JX Holdings, Inc.:企業の戦略・SWOT・財務情報
    JX Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JX Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ATGen Co Ltd (182400):製薬・医療:M&Aディール及び事業提携情報
    Summary ATGen Co Ltd (ATGen) is a manufacturer and supplier of proteins and monoclonal antibodies. The company offers neuroproteins, enzymes, heat shock proteins, ubiquitins, cancer related proteins, antibodies, viral antigens and hormones. It conducts research and development of medicines based on …
  • Hindustan Unilever Ltd (HINDUNILVR):企業の財務・戦略的SWOT分析
    Hindustan Unilever Ltd (HINDUNILVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆